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isk stratification plays an important role in surgical specialties worldwide.
Multivariable models are used to assess the clinical outcomes in an objective
risk-adjusted manner and allow useful comparisons to bemade between coun-
tries, regions, hospitals, and individual surgeons. The Society of Thoracic Surgeons
(STS) Adult Cardiac Surgery Database in the United States has been one of the biggest
and most reliable risk-adjusted databases, and it is the gold standard for clinical data
analysis in the field of cardiac surgery. Similarly, the open source algorithm of the
European System for Cardiac Operative Risk Evaluation (EuroSCORE), which was
developed in Europe, represents another reliable, widely established and validated
model for risk stratification in the entire context of cardiac surgery.
During the past 15 years, while STS and EuroSCORE algorithms were developed,
thoracic surgery is lacking an accepted general model for in-hospital mortality. Re-
cently, Thoracoscore became available, and it is the first multivariatemodel for the pre-
diction of in-hospital mortality in the entire context of thoracic surgery.1 Thoracoscore
was developed from 15,183 patientswho underwent thoracic surgery in 59 French hos-
pitals. In the meanwhile, the corresponding General Thoracic Database of the STS is
still under development, accounting for 49,000 patients (1999–2006). However, there
is no risk stratificationmodel published to date from this North American database. All
the aforementioned indicate that the risk stratification in thoracic surgery is in its birth
and early stages. There are many reasons for general thoracic surgeons to help in the
progression and the development of risk stratification in thoracic surgery, such as qual-
ity improvements in patient care and patient outcomes, differentiation from surgeons
who are less qualified to perform thoracic surgery, recertification of surgeons, costs of
surgery, and pay for performance.2
Thoracoscore is a reliable risk stratification model because it comes from a national
electronic prospective database and therefore has the potential to reach an international
consensus. Our research team has published the first study evaluating the performance
of Thoracoscore in an external database.3 The conclusions of our study are supportive
and encouraging. First, we evaluated the performance of Thoracoscore in a North
American single-center cohort of patients with the entire context of thoracic surgery,
and it showed excellent discriminatory ability and calibration in predicting in-hospital
mortality. Second, we extended the usefulness of Thoracoscore with respect to mid-
term all-cause mortality prediction. Indeed, Thoracoscore showed very good discrim-
inatory ability in predicting 2-year survival after thoracic surgery. Although in our
study one of the original variables of the Thoracoscore was not available (dyspnea
score), we concluded that it is a good clinical tool for preoperative prediction of in-
hospital and midterm mortality among patients undergoing general thoracic surgery.
Given the fact that Thoracoscore is the first step of risk stratification in thoracic sur-
gery, the question regarding the future of risk stratification in this surgical field needs
to be addressed to determine the next steps. A good example to reach an international
consensus is the EuroSCORE development. EuroSCORE was first introduced in
1999, and there are 323 publications to date in the English language (March 2008)
validating its algorithm throughout Europe, North America, and Asia. In addition,
EuroSCORE has been proved to be a good predictor for major postoperative compli-
cations, costs, midterm survival, and long-term survival after cardiac surgery.4-7
Therefore, the evaluation of these outcomes in thoracic surgery by Thoracoscore or
any other new score may help in the establishment of a useful multipurpose clinical
tool.The Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 7
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LFigure 1. Time intervals after thoracic surgery.
ICU, Intensive care unit.At present,most surgical registriesmonitor patients only to
the point of discharge from the hospital. However, it is widely
known that in-hospital adverse events represent only one as-
pect of the periprocedural outcome. It is important to mention
that the STSNational Database aims to expand its capabilities
to perform long-term follow-up using the National Death
Index. Unique patient, surgeon, and hospital identifier fields
have already been added to the STS Adult Cardiac Surgery
Database beginning in January 2008, and similar fields will
be added to the STS General Thoracic Surgery Database.
The sensitivity of the National Death Index to identify deaths
is between 92% and 99% depending on which identifiers are
available. Social Security number alone has the best accuracy
of any combination of other identifiers with a sensitivity of
97% and a specificity of 99%.8 The use of Social Security
numbers in the STS databases will enable them to generate
Kaplan–Meier survival curves, aswell as to performmultivar-
iate Cox regression analysis for long-term outcomes. The Na-
tional Death Index can provide rapid and objective long-term
survival results, particularly when used with specific software
such as we have developed, with which thousands of queries
can be obtained accurately in minutes.9
Figure 1 determines different time intervals after surgery.
In-hospital stay is the target period for most stratification sys-
tems in cardiothoracic surgery. Early postdischarge period
(first months after discharge up to 1 year after discharge) rep-
resents a very important period in risk stratification, because
adverse events and complications directly related to the sur-
gical procedure may also occur during this time interval. Fur-
thermore, the midterm period (up to 5 years) could be an ideal
time interval to extract conclusive and safe results for the out-
come of a procedure. Finally, long-term follow-up (10 years
or more) is needed in some cases to determine the efficacy of
the procedure as well as to compare the outcomewith the gen-
eral population. Therefore, future risk stratification models in
thoracic surgery should take into consideration midterm and
long-term outcomes.
The next important step is to determine the outcome. Most
risk stratification models in cardiothoracic surgery have been
developed for the prediction of in-hospital mortality. Refine-
ments in surgical techniques and improvements in anesthetic
management and intensive care unit monitoring have resulted
in reduced operativemortality. In this aspect, the development
of risk stratification models for the prediction of in-hospital8 The Journal of Thoracic and Cardiovascular Surgery c July 2mortality requires the analysis of relatively large patient pop-
ulations. On the other hand, major postoperative complica-
tions are also important and affect both in-hospital and
midterm survival.7,10 Therefore, the prediction of major post-
operative complications could help in improving patient selec-
tion for surgery, stratifying patients, and enhancing informed
consent, as well as assigning resources for postoperative man-
agement. Another important issue is to demarcate disease or
surgery-specific mortality from all-cause mortality. For in-
hospital mortality it may be easy to document the cause of
death, but for long-term mortality there is no source to deter-
mine the cause of death, in as much as the National Death In-
dex can provide data only for the survival status and the date of
death. The characterization of disease-specific mortality
during midterm and long-term follow-up periods remains un-
solved and should be addressed by large databases to enhance
them with the ability to provide more accurate long-term re-
sults based only on the analysis of the disease-specific out-
come. Another important adverse event is the recurrence of
the disease during the midterm or long-term period. It seems
difficult to assess this outcome given the fact that usually the
patient is been followed up by other specialists (ie, oncologists
or family physicians). Finally, one of the most important out-
comes for the patient is the quality of life after surgery. Even in
cardiac surgery there is a paucity of risk stratification models
with respect to quality of life after surgery. Such models are
very important because the purpose of surgery is not only to
ensure survival of the patient, but also to allow for a quality
of life that is similar to or close to that of the general popula-
tion. Table 1 summarizes these outcomes. All-cause and dis-
ease-specific mortality can be assessed at all time intervals,
TABLE 1. Different types of adverse events and outcome
after thoracic surgery
Outcome In-hospital
Early after
discharge
Midterm
period
Long-term
period
All-cause mortality O O O O
Disease-specific
mortality
O O O O
Postoperative
complications
O O — —
Disease recurrence — O O O
Quality of life — O O O008
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LTABLE 2. Potential risk factors affecting outcomes after thoracic surgery
Preoperatively known or unknown Occur intraoperatively Occur postoperatively
Traditional risk factors Genetic risk factors Intraoperative risk factors Follow-up risk factors
Cardiac function Gene polymorphisms Anesthetic management Follow-up frequency
Pulmonary function Transcriptional levels Technical issues Pharmacologic therapy
Renal function Protein polymorphisms Duration of the operation Readmission
Age Protein levels Completeness—successful Re-intervention
etc etc etc etcpostoperative complications usually occur during hospital
stay and rarely during early postdischarge period, and disease
recurrence and quality of life can be assessed after discharge
from the hospital.
Finally, it is important tomention potential risk factors that
the risk stratification models should take into consideration
(Table 2). At present, risk stratification models include demo-
graphic and traditional risk factors primarily related to car-
diac, pulmonary, and renal function, as well as smoking,
diabetes, and peripheral vascular disease. In elective surgical
procedures, these preoperative characteristics are available
and can be used for the estimation of in-hospital mortality
risk or major postoperative complications in some other algo-
rithms. In addition to the preoperative traditional risk factors,
there are also intraoperative factors (ie, anesthetic manage-
ment, completeness of tumor and lymph node resection, and
duration of the operation) that also affect early and long-
term outcome. Indeed, some risk factors acting during the
midterm or long-term postoperative period (ie, conservative
therapy, follow-up visits, and reinterventions) could also
represent important independent predictors of long-term out-
come. It is, therefore, obvious that risk stratification begins
with the evaluation of preoperative risk factors, but it can
also be reconsidered including intraoperative and postopera-
tive risk factors affecting long-term outcome. Moreover, in
the era of molecular biology, future risk stratification models
face the challenge to include in their algorithms genetic risk
factors. It is expected that the inclusion of specific gene and
protein polymorphisms, as well as the levels of normal pro-
teins related to the disease, will further increase the discrimi-
natory ability of the risk stratification models. Despite the
substantial progress in risk stratification modeling in cardiac
surgery, there is no risk stratificationmodel for individual pre-
diction, and as a consequence all algorithms can be used for
the estimation of the risk for the outcome used. Similarly,
risk stratification models in thoracic surgery are expected
to be used for the estimation of the risk for which have been
developed. Genetic risk factors may be the key element for
achieving individual prediction, but much more work needs
to be done, at the moment, for the identification of the genes
and proteins, which are associated with thoracic surgical dis-
eases. We have also proposed the development of risk strati-
fication models for the assessment of quality of life afterThe Journal of Tsurgery. In this aspect, psychosocial risk factors (ie, anxiety
and depression) should be also taken into consideration.
In conclusion, all the above show clearly that risk stratifica-
tion in thoracic surgery is in its early stages and many studies
are needed to reach the progress that has already beenmade in
the field of cardiac surgery. Given the successful story of the
STSAdult Cardiac Surgery Database, we are looking forward
to seeing the first risk stratification algorithm from the STS
General Thoracic Surgery Database, which will also be
a good standard for comparison with the Thoracoscore. The
real challenge, however, is to develop a risk stratification
model including traditional risk factors along with genetic
and psychosocial risk factors with respect to long-term out-
come to improve the quality of life of our patients and be in ac-
cordance with Hippocrates: ‘‘to help, or at least do no harm.’’
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